dc.contributor
Institut Català de la Salut
dc.contributor
[Garralda E] Research Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Laurie SA] Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Canada. [Seymour L] Canadian Cancer Trials Group, Queens University, Cancer Centre of South Eastern Ontario, Kingston, ON, Canada. [de Vries EGE] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Laurie, Scott
dc.contributor.author
Seymour, Lesley
dc.contributor.author
de Vries, Elisabeth
dc.contributor.author
GARRALDA, Elena
dc.date.accessioned
2025-10-25T05:39:34Z
dc.date.available
2025-10-25T05:39:34Z
dc.date.issued
2023-07-04T06:51:40Z
dc.date.issued
2023-07-04T06:51:40Z
dc.date.issued
2023-05-24
dc.identifier
Garralda E, Laurie SA, Seymour L, de Vries EGE. Towards evidence-based response criteria for cancer immunotherapy. Nat Commun. 2023 May 24;14:3001.
dc.identifier
https://hdl.handle.net/11351/9953
dc.identifier
10.1038/s41467-023-38837-3
dc.identifier
001001099700021
dc.identifier.uri
http://hdl.handle.net/11351/9953
dc.description.abstract
Cáncer; Inmunología tumoral
dc.description.abstract
Càncer; Immunologia tumoral
dc.description.abstract
Cancer; Tumour immunology
dc.description.abstract
Early detection of immunotherapy-induced tumor response is of major benefit for patients but can be complicated by therapy-induced pseudoprogression. A consensus guideline-iRECIST- was developed as a modification of Response Evaluation Criteria in Solid Tumours (RECIST version 1.1). Here we describe which next steps are required to test its validity and how novel approaches for response criteria might be developed and included.
dc.format
application/pdf
dc.publisher
Nature Portfolio
dc.relation
Nature Communications;14
dc.relation
https://doi.org/10.1038/s41467-023-38837-3
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Càncer - Immunoteràpia
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy
dc.subject
DISEASES::Neoplasms
dc.subject
Other subheadings::Other subheadings::/therapy
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia
dc.subject
ENFERMEDADES::neoplasias
dc.subject
Otros calificadores::Otros calificadores::/terapia
dc.title
Towards evidence-based response criteria for cancer immunotherapy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
